ArticleClinical oral investigations2025
An in vitro study on the antimicrobial efficacy of a calcium hydroxide versus a calcium silicate-based endodontic medicament.
Article in Clinical oral investigations, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Different irrigation solutions in calcium hydroxide removal: Do high-frequency ultrasonic and laser activation make the difference?Lasers in medical science · 2026Article
- Effect of Root Canal Dressings on Extraradicular pH in a Sealed Apex Model: An In Vitro Study.Clinical and experimental dental research · 2026Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND AND
objectivesIntracanal medicaments are essential adjuncts to chemo-mechanical canal preparation when controlling endodontic infections; however, their antibacterial action may not be uniform due to the diversity of the involved species. This study aimed to compare the long-term antimicrobial efficacy, metabolic activity, and pH of two intracanal medicaments: calcium silicate-based BC Temp (BC) and DEHP calcium hydroxide (CH). MATERIALS AND
methodsThe pH was examined over a 28-day period with and without freshly extracted tooth-root sections. Antimicrobial activity was assessed using a direct contact test (DCT) against Enterococcus faecalis, Streptococcus mitis/oralis, Cutibacterium acnes, and Staphylococcus epidermidis, by quantifying colony-forming units (CFU). The metabolic activity and cell viability were measured using the colorimetric 2,3-Bis-(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-Carboxanilide (XTT) assay. Statistical analysis was conducted using a two-way analysis of variance (ANOVA) followed by a post-hoc Tukey's and Šídák's tests.
resultsBoth CH and BC demonstrated high alkalinity (pH 11–13), with CH maintaining higher pH for a longer period (14 days) compared to BC (7 days). No significant differences were observed when the pH of HBSS was measured with or without a sectioned tooth-root surface in contact with tested medicaments. Both medicaments exhibited effective antimicrobial activity against the tested planktonic bacteria. CH demonstrated rapid and superior antibacterial efficacy against E. faecalis and S.epidermidis at 48 h, while BC, which has a smaller particle size, sustained CFU reduction at later time points (21 and 28 days), particularly against S.mitis/oralis, S.epidermidis, and E.faecalis. Furthermore, the XTT assay indicated reduced cell viability following treatment with both CH and BC, with BC demonstrating a more stable effect over time and maintaining cell viability below 50% across all bacterial groups during 28-day period.
conclusionsWhile maintaining a pH similar to that of CH, which has a well-established antibacterial effect; the calcium silicate-based BC Temp exhibited enhanced antimicrobial activity against the tested bacteria.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.